- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Total 322 results
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...RecruitingHematological TumorsChina
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...TerminatedAdvanced High-grade SarcomaChina
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...RecruitingDiabetes Mellitus, Type 2China
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...RecruitingMantle Cell LymphomaChina
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...RecruitingAdvanced Malignant TumorChina
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Terminated
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingHematologic MalignancyChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingBiliary CarcinomaChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAtopic DermatitisChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRheumatoid ArthritisChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRecurrent Squamous Cell Carcinoma of the Head and Neck | Metastatic Squamous Cell CarcinomaChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingChronic Kidney Diseases | Magnetic Resonance ImagingChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced Malignant TumorChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingHR-positive,HER2-negative in Advanced Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingChronic Obstructive Pulmonary Disease (COPD)China
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced Malignant TumorsChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingType I NeurofibromatosisChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingUnresectable Metastatic Colorectal CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingModerate and High Risk MyelofibrosisChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingMetastatic Castration-resistant Prostate CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingA Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical CancerRecurrent or Metastatic Cervical CancerChina